ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 665759 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 665759; 2) Community: the network communities that were significantly associated with the response to NSC 665759; 3) Molecule: the relationships between components within communities and NSC 665759; 4) MDR: the compounds that were significantly associated with the NSC 665759.

NSC Compound Enrichment Correlation
NSC 707055 Null 0.0248868750898605 0.23298033
NSC 762583 Null 0.0248868750898605 -0.072555765
NSC 128571 Ethanesulfonic acid, compd. with 2-chloro-5-[4-[2-chloro-4-(4,6-diamino-2,2-dimethyl-s-triazin-1(2H)-yl)phenyl]butyl]benzenesulfonyl fluoride (1:1) (8CI) 0.0283958753782624 -0.030473822
NSC 143925 Pekilocerin A 0.0283958753782624 -0.054184236
NSC 169774 Bromocriptine methanesulfonate 0.0283958753782624 0.20186532
NSC 237020 TA 1067 0.0283958753782624 0.066626951
NSC 290193 CYCLOSPORIN A 0.0283958753782624 0.28578978
NSC 3061 BW 50-63 0.0283958753782624 0.045182774
NSC 335766 Quinazoline, 4-ethyl-6-methoxy-7-(oxiranylmethoxy)- 0.0283958753782624 0.0092643053
NSC 339638 2H-Pyran-2-one, 5,6-dihydro-6-[3,6,13-trihydroxy-3-methyl- 4-(phosphonooxy)-1,7,9,11-tridecatetraenyl]-, monosodiumsalt 0.0283958753782624 0.30798733
Total:95  Current:54    [First] [Prev] [Next] [Last]